- Report
- February 2025
- 137 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- October 2024
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- May 2024
- 186 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- March 2025
- 466 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- January 2025
- 146 Pages
Global
From €3353EUR$3,528USD£2,817GBP
€3945EUR$4,150USD£3,314GBP
- Report
- January 2025
- 148 Pages
Global
From €2757EUR$2,900USD£2,316GBP
- Report
- August 2024
- 158 Pages
Global
From €1232EUR$1,341USD£1,000GBP
- Report
- December 2024
- 262 Pages
Global
From €2329EUR$2,450USD£1,957GBP
- Report
- February 2025
- 148 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- January 2025
- 125 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- July 2024
- 138 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- March 2025
- 184 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 193 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 199 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- August 2024
- 144 Pages
Global
From €2851EUR$2,999USD£2,395GBP
- Report
- October 2024
- 186 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- March 2025
- 183 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- October 2024
- 198 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- December 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP

The Bioactive Compound market is a subset of the biotechnology industry that focuses on the development and production of compounds with biological activity. These compounds are used in a variety of applications, including drug discovery, diagnostics, and therapeutics. Bioactive compounds are typically derived from natural sources, such as plants, animals, and microorganisms, and are often modified to enhance their activity. The market is driven by the increasing demand for new and improved treatments for a variety of diseases, as well as the need for more efficient and cost-effective drug discovery processes.
The Bioactive Compound market is highly competitive, with a number of companies offering a range of products and services. Major players in the market include Merck, Pfizer, Novartis, and Roche. Other notable companies include AbbVie, AstraZeneca, and GlaxoSmithKline. Show Less Read more